The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Formulary messaging clarification
Miscellaneous
3
Posts
2
Posters
39
Views
1
Watching
-
Hi there,
I’m seeking clarification on the rules around formulary messaging. Specifically:
-
I understand that therapeutic claims must be separate from formulary information, but can both appear within the same piece as long as they are clearly distinct?
-
Are formulary claims permitted to be combined with non-therapeutic messages (ex: experience claims)?
-
Finally, can formulary messaging be directed to patients to inform them of coverage in their province? I understand that this is acceptable in a DTC context, but I’d like to confirm whether this is also permitted in patient-directed materials (ex: “Now covered on ODB”).
Thank you for your guidance.
Adelaide
-
-
Hey @adelaidebaker
- Yes.
- Experience claims should not be positioned in a manner which suggests significance to the listing or vise versa. It cannot be stated or inferred that the experience is linked to coverage or that coverage is due to the experience.
- Patient information should be informational and not promotional. The copy “Now covered on ODB” would be considered promotional. For acceptable communications around formulary coverage, see Guidance on branded patient information section 1.3 Formulary Statements.
-
Thank you!
